BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2024 3:55:02 PM | Browse: 97 | Download: 309
 |
Received |
|
2024-03-09 11:26 |
|
Peer-Review Started |
|
2024-03-09 11:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-16 21:09 |
|
Revised |
|
2024-04-23 15:38 |
|
Second Decision |
|
2024-04-29 03:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-04-29 09:02 |
|
Articles in Press |
|
2024-04-29 09:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-27 15:44 |
|
Publish the Manuscript Online |
|
2024-06-04 15:55 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Renin-angiotensin system inhibitor prescriptions in Chinese hospitalized chronic kidney disease patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chun Zhang, Zhi-Yu Duan, Sa-Sa Nie, Zhou Zhang, Xin-Ru Guo, Chao-Yang Zhang, Jing Dong and Guang-Yan Cai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guang-Yan Cai, PhD, Chief Physician, Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing 100853, China. vinxiong66@163.com |
| Key Words |
Chronic kidney disease; Renin-angiotensin system inhibitors; Prescriptions; Adherence |
| Core Tip |
This study examines the prescribing trends of renin-angiotensin system inhibitors (RASI) in hospitalized Chinese chronic kidney disease (CKD) patients from 2010 to 2019. Despite guidelines recommending RASI as first-line therapy, findings reveal a peak in prescriptions around 2015-2016, followed by a slight decline. Factors such as younger age, male gender, and non-acute conditions increased RASI prescription likelihood. The research highlights a need for improved adherence to clinical guidelines in RASI application to enhance CKD patient care outcomes. |
| Publish Date |
2024-06-04 15:55 |
| Citation |
<p>Zhang C, Duan ZY, Nie SS, Zhang Z, Guo XR, Zhang CY, Dong J, Cai GY. Renin-angiotensin system inhibitor prescriptions in Chinese hospitalized chronic kidney disease patients. <i>World J Clin Cases</i> 2024; 12(17): 3061-3075</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i17/3061.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i17.3061 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
